Have you accessed ENHERTU®, or provided care for someone who has?
Patient organizations are gathering input from patients and caregivers to support a funding review of trastuzumab deruxtecan (ENHERTU®) in Canada.
We are seeking individuals who have accessed ENHERTU® to participate in a confidential 45-minute telephone interview to share their lived experience with cancer and treatment. Participation is welcome whether you are a patient or a caregiver.
Your voice can help shape others' access to this therapy.
-------------------------------------------